Vaccinating adolescents against SARS-CoV-2 in England: a risk–benefit analysis
Volume: 114, Issue: 11, Pages: 513 - 524
Published: Nov 1, 2021
Abstract
To offer a quantitative risk-benefit analysis of two doses of SARS-CoV-2 vaccination among adolescents in England.England.Following the risk-benefit analysis methodology carried out by the US Centers for Disease Control, we calculated historical rates of hospital admission, Intensive Care Unit admission and death for ascertained SARS-CoV-2 cases in children aged 12-17 in England. We then used these rates alongside a range of estimates for...
Paper Details
Title
Vaccinating adolescents against SARS-CoV-2 in England: a risk–benefit analysis
Published Date
Nov 1, 2021
Volume
114
Issue
11
Pages
513 - 524
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History